Spanish stocks - Factors to watch on Jan 24

Jan 18 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy

Jan 17 (Reuters) - Oryzon Genomics SA: * ANNOUNCES CONVERSION OF CONVERTIBLE BONDS * INVESTOR NICE & GREEN HAS REQUESTED A NEW CONVERSION OF BONDS FOR AN AMOUNT JOINT FACE VALUE OF 1.9 MILLION EUROS,

Jan 11 (Reuters) - Prim SA: * EARLY TERMINATION OF BUY-BACK PROGRAMME * COMPANY HAS REACHED AMOUNT OF EUR 998,942.85 TERMINATING OWN SHARES REPURCHASE PROGRAMME, PRIOR TO EXPIRATION DATE SET FOR JAN

Jan 11 (Reuters) - Grifols SA: * ACHIEVES POSITIVE TOPLINE RESULTS FROM PHASE 3B STUDY OF ITS FIBRIN SEALANT TO TREAT SURGICAL BLEEDING IN PEDIATRIC PATIENTS * ALL PRIMARY AND SECONDARY ENDPOINTS MET,

Dec 30 (Reuters) - Atrys Health SA: * APPROVES CAPITAL INCREASE OF COMPANY BY OFFSETTING CREDITS FOR TOTAL NOMINAL AMOUNT OF 6,093.92 EUROS AND A TOTAL SHARE PREMIUM OF 4.3 MILLION EUROS BY ISSUING

Dec 30 (Reuters) - Pharma Mar SA: * INITIATES FIRST HUMAN CLINICAL TRIAL OF A NEW MOLECULE, PM534, FOR CANCER PATIENTS * NEW MOLECULE HAS BEEN TESTED IN THE LABORATORY, BOTH IN CELL CULTURES (IN VITRO

Dec 28 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy

Dec 28 (Reuters) - Atrys Health: * SAID ON WEDNESDAY IT ACQUIRED 100% OF INITIA ONCOLOGIA AND 70% OF INITIA RESEARCH (INITIA) * AGGREGATE AMOUNT PAID FOR BOTH COMPANIES AMOUNTS TO 2.3 MILLION EUROS (

Dec 23 (Reuters) - Atrys Health SA: * SAID ON THURSDAY SIGNED CONTRACT TO SELL 24.9% OF SHARES OF PROFESSIONAL GROUP CONVERSIA TO ARRAIGO NW SEGUNDO * AGREED PRICE AMOUNTS TO 20 MILLION EUROS, OF

Dec 22 (Reuters) - Pharma Mar SA: * LEADS TERINMUN INITIATIVE, RESEARCH CONSORTIUM IN SEARCH OF IMMUNOTHERAPIES BASED ON MARINE-DERIVED COMPOUNDS * PROJECT APPROVED IN CALL FOR PUBLIC-PRIVATE